Tandem Mass Tags Quantitative Proteomics Reveal the Mechanism by Which Paeoniflorin Regulates the PI3K/AKT and BDNF/CREB Signaling Pathways to Inhibit Parkinson’s Disease
Open Access
- 6 July 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (13) , 6498
Abstract
Paeoniflorin (PF), a monomeric compound extracted from the dry roots of Paeonia lactiflora, has been widely used in the treatment of nervous system diseases, marking it as a critical formula in Parkinson’s disease (PD). However, the action of PF against PD and its molecular mechanism are still unclear. In this study, tandem mass tags quantitative proteomics was performed to systematically clarify the underlying mechanism of action of PF against PD and to confirm it using in vivo and in vitro studies. The results showed that PF notably enhanced the viability of PC12 cells and mitigated MPP+-induced mitochondrial dysfunction, oxidative stress, and apoptosis. Tandem mass tag-based quantitative proteome analysis revealed the identification of 6405 proteins, of which 92 were downregulated and 190 were upregulated. Among them, the levels of PI3K, AKT, CREB, and BDNF in the MPP+-induced PC12 cell and MPTP mice were considerably lower than in the control group, indicating the role of the BDNF/CREB pathway in the pathogenesis of neuroprotection. The related DEP (PI3K, AKT, CREB, and BDNF) expression levels were verified by Western blot. PF effectively restored the altered expression of the four DEPs induced by MPP+ and MPTP. Summarily, PF exerted remarkable neuroprotective effects in MPP+-induced PC12 cell and MPTP-induced mice. Further, our research may provide proteomics insights that contribute to the further exploration of PF as a potential treatment for PD.Keywords
Funding Information
- Natural Science Foundation of Jilin Province, China (20250601064R)
This publication has 51 references indexed in Scilit:
- Formoterol attenuated mitochondrial dysfunction in rotenone-induced Parkinson's disease in a rat model: Role of PINK-1/PARKIN and PI3K/Akt/CREB/BDNF/TrKB axisInternational Immunopharmacology, 2023
- PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson’s disease in ratsInflammopharmacology, 2023
- Serum BDNF levels are involved in the diagnosis and treatment response in patients with PDJournal of Affective Disorders, 2023
- Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinomaProteomics, 2023
- Treating Parkinson's Disease via Activation of BDNF/TrkB Signaling Pathways and Inhibition of Delta-SecretaseNeurotherapeutics, 2022
- Curcumin can improve Parkinson's disease via activating BDNF/PI3k/Akt signaling pathwaysFood and Chemical Toxicology, 2022
- Expression of BDNF-Associated lncRNAs in Parkinson’s diseaseMetabolic Brain Disease, 2022
- Neuroprotective action of agmatine in rotenone-induced model of Parkinson’s disease: Role of BDNF/cREB and ERK pathwayBehavioural Brain Research, 2020
- Paeoniflorin improves pressure overload-induced cardiac remodeling by modulating the MAPK signaling pathway in spontaneously hypertensive ratsBiomedicine & Pharmacotherapy, 2019
- Attenuation of Cisplatin-Induced Neurotoxicity by Cyanidin, a Natural Inhibitor of ROS-Mediated Apoptosis in PC12 CellsCellular and Molecular Neurobiology, 2015